Optimizing chemotherapy for frail and elderly patients with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trial
dc.contributor.author | Hall, P | |
dc.contributor.author | Swinson, D | |
dc.contributor.author | Lord, S | |
dc.contributor.author | Marshall, H | |
dc.contributor.author | Cairns, D | |
dc.contributor.author | Ruddock, S | |
dc.contributor.author | Batman, E | |
dc.contributor.author | Velikova, G | |
dc.contributor.author | Petty, R | |
dc.contributor.author | Waters, J | |
dc.contributor.author | Wadsley, J | |
dc.contributor.author | Falk, S | |
dc.contributor.author | Handforth, C | |
dc.contributor.author | Roy, R | |
dc.contributor.author | Joseph, M | |
dc.contributor.author | Kamposioras, K | |
dc.contributor.author | Nicoll, J | |
dc.contributor.author | Tillett, T | |
dc.contributor.author | Cummins, S | |
dc.contributor.author | Grumett, S | |
dc.contributor.author | Stokes, Z | |
dc.contributor.author | Waddell, Thomas | |
dc.contributor.author | Chatterjee, A | |
dc.contributor.author | Garcia, A | |
dc.contributor.author | Allmark, C | |
dc.contributor.author | Seymour, M | |
dc.date.accessioned | 2020-01-29T15:17:53Z | |
dc.date.available | 2020-01-29T15:17:53Z | |
dc.date.issued | 2019 | en |
dc.identifier.citation | Hall P, Swinson D, Lord S, Marshall H, Cairns D, Ruddock S, et al. Optimizing chemotherapy for frail and elderly patients with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trial. British Journal of Cancer. 2019;121:43912 | en |
dc.identifier.uri | http://hdl.handle.net/10541/622701 | |
dc.language.iso | en | en |
dc.title | Optimizing chemotherapy for frail and elderly patients with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trial | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | University of Edinburgh, Edinburgh | en |
dc.identifier.journal | British Journal of Cancer | en |
dc.description.note | en] |